click below
click below
Normal Size Small Size show me how
Pain/Heme/Onc 2
Pain, Hematology and Oncology 2
| Generic | Brand | Pharmacologic Category | Common Indications | Key Side Effects | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| hydrocodone and acetaminophen (PO) | Lortab, Vicodin, Norco | Opioid and nonopioid analgesic combination | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | risk of addiction, abuse/misuse, neonatal induced w/drawl syndrome; concomitant w/benzos, alcohol (CNS depressants) lead to profound sedation, respiratory depression, and death | |
| oxycodone and acetaminophen (PO) | Percocet, Endocet, Roxicet | Opioid and nonopioid analgesic combination | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | risk of addiction, abuse/misuse, neonatal induced w/drawl syndrome; concomitant w/benzos, alcohol (CNS depressants) lead to profound sedation, respiratory depression, and death; CYP3A4i can inc [Oxy]; hepatotoxicity | |
| codeine and acetaminophen (PO) | Tylenol with Codeine #3, Tylenol with Codeine #4 | Opioid and nonopioid analgesic combination | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | risk of addiction, abuse/misuse, neonatal induced w/drawl syndrome; concomitant w/benzos, alcohol (CNS depressants) lead to profound sedation, respiratory depression, and death | |
| naloxone (IV, IM, SQ, intranasal) | Narcan | Opioid antagonist | Opioid overdose | opioid withdrawal syndrome in opioid-dependent populations, pain | potentially life-threatening respiratory depression (when combined with other CNS and respiratory depressants); addition of naloxone to buprenorphine reduces possibility of parenteral misuse by producing opioid withdrawal symptoms when injected | |
| buprenorphine and naloxone (SL) | Suboxone | Partial opioid agonist and opioid antagonist | Opioid use disorder | headache, opioid withdrawal syndrome in opioid-dependent populations, pain, diaphoresis, constipation | potentially life-threatening respiratory depression (when combined with other CNS and respiratory depressants); addition of naloxone to buprenorphine reduces possibility of parenteral misuse by producing opioid withdrawal symptoms when injected | |
| ferrous sulfate (PO) * | FeroSul, SlowFe | Iron supplement | Iron deficiency anemia | nausea, stomach upset, constipation (dose-related), dark and tarry stools | Accidental overdose of iron is leading cause of fatal poisoning in children under 6 years old | |
| cyanocobalamin (vitamin B12) (PO, IM, SL, intranasal) * | --- | Water-soluble vitamin | Vitamin B12 deficiency (manifests as macrocytic anemia) | |||
| folic acid (PO) * | --- | Water-soluble vitamin | Folic acid deficiency (manifests as macrocytic anemia), prevention of neural tube defects in pregnancy |